dr. plimack on frontline pembrolizumab for urothelial carcinoma
Published 7 years ago • 65 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:18
dr. plimack on keynote-045 trial for pembrolizumab in urothelial carcinoma
-
1:18
dr. plimack on combo of pembrolizumab/epacodostat in bladder cancer
-
0:55
dr. plimack on frontline checkpoint inhibitors in bladder cancer
-
0:53
dr. plimack on strategies for developing cure for locally advanced urothelial carcinoma
-
1:44
dr. plimack on a phase ib study of pembrolizumab in bladder cancer
-
1:36
pembrolizumab in urothelial cancer
-
1:05
dr. petrylak on combinations with pembrolizumab in urothelial carcinoma
-
0:47
dr. balar on combinations with pembrolizumab for urothelial cancer
-
1:04
dr. plimack on immunotherapy combinations in bladder cancer
-
0:47
dr. plimack on the challenges with available immunotherapies for bladder cancer
-
2:21
dr. galsky on maintenance pembrolizumab in urothelial cancer
-
1:00
dr. plimack on the growth of immunotherapy in bladder cancer
-
0:49
dr. elizabeth plimack on immunotherapy potential in bladder cancer
-
1:35
dr. plimack on choosing a checkpoint inhibitor in bladder cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
1:14
dr. plimack on second-line checkpoint inhibitors in bladder cancer
-
1:34
dr. garcia on fda approval of pembrolizumab in bladder cancer
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
1:39
dr. elizabeth plimack on nivolumab in kidney cancer